首页> 美国卫生研究院文献>ESMO Open >Association of improved overall survival with decreased distant metastasis following asparaginase-based chemotherapy and radiotherapy for intermediate- and high-risk early-stage extranodal nasal-type NK/T-cell lymphoma: a CLCG study

【2h】

Association of improved overall survival with decreased distant metastasis following asparaginase-based chemotherapy and radiotherapy for intermediate- and high-risk early-stage extranodal nasal-type NK/T-cell lymphoma: a CLCG study

机译：基于烷淀戳酶的化疗和放射治疗的中间和高风险早期外鼻鼻型NK / T细胞淋巴瘤的远处转移随着远程转移而改善的整体生存结合随着远程转移而降低

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

This study evaluated the survival benefit of asparaginase (ASP)-based versus non-ASP-based chemotherapy combined with radiotherapy in a real-world cohort of patients with early-stage extranodal nasal-type natural killer/T-cell lymphoma (ENKTCL).

机译：该研究评估了浅杀蛋白酶（ASP）的生存效益 - 基于与非ASP基化学疗法相结合，其在现实世界队列患者的早期外鼻型天然杀伤/ T细胞淋巴瘤（ENKTCL）中的患者的真实世界队列中的放射治疗。

著录项

期刊名称 ESMO Open
作者
X. Zheng; X. He; Y. Yang; X. Liu; L.L. Zhang; B.L. Qu; Q.Z. Zhong; L.T. Qian; X.R. Hou; X.Y. Qiao; H. Wang; Y. Zhu; J.Z. Cao; J.X. Wu; T. Wu; S.Y. Zhu; M. Shi; L.M. Xu; H.L. Zhang; H. Su; Y.Q. Song; J. Zhu; Y.J. Zhang; H.Q. Huang; Y. Wang; F. Chen; L. Yin; S.N. Qi; Y.X. Li;
展开▼
作者单位

展开▼
年(卷),期 2021(6),4
年度 2021
页码 100206
总页数 11
原文格式 PDF
正文语种
中图分类
关键词

机译：NK / T细胞淋巴瘤;天冬酰胺酶;化疗;放射治疗;生存结果;

相似文献

外文文献
中文文献

1. Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG) [J] . Xiu-Wen Deng, Jun-Xin Wu, Tao Wu, Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology . 2018,第1期

机译：在早期外鼻型NK / T细胞淋巴瘤中完全反应含天冬酰胺酶的化疗后完全反应，放射疗法是必不可少的：中国淋巴瘤协作组的多中心研究（CLCG）
2. Effect of primary tumor invasion on treatment and survival in extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: a multicenter study from the China Lymphoma Collaborative Group (CLCG) [J] . Shu-Nan Qi, Li-Ming Xu, Zhi-Yong Yuan, Leukemia and lymphoma . 2019,第11a12期

机译：原发性肿瘤侵袭对现代化疗时代外鼻型NK / T细胞淋巴瘤治疗和存活的影响：中国淋巴瘤协作组的多中心研究（CLCG）
3. Curability of Radiotherapy in Elderly Patients with Earlystage Extranodal Nasal-type NK/T-cell Lymphoma: A Multicenter Study from the China Lymphoma Collaborative Group (CLCG) [J] . Chen B., Zhu S. Y., Shi M., International Journal of Radiation Oncology, Biology, Physics . 2018,第3Suppla期

机译：老年早期患者放射治疗的可固化性外鼻鼻型NK / T细胞淋巴瘤：中国淋巴瘤协作组的多中心研究（CLCG）
4. Effect of age as a continuous variable on survival outcomes and treatment selection in patients with extranodal nasal-type NK/T-cell lymphoma from the China Lymphoma Collaborative Group (CLCG) [O] . Wei-Xin Liu, Mei Shi, Hang Su, 2019

机译：年龄作为连续变量对中国淋巴瘤协作组（CLCG）结外鼻型NK / T细胞淋巴瘤患者生存结局和治疗选择的影响
5. Effect of age as a continuous variable on survival outcomes and treatment selection in patients with extranodal nasal-type NK/T-cell lymphoma from the China Lymphoma Collaborative Group (CLCG) [O] . Wei-Xin Liu, Mei Shi, Hang Su, 2019

机译：年龄作为连续变量对来自中国淋巴瘤的鼻腔型NK / T细胞淋巴瘤（CLCG）患者患者的生存结果和治疗选择

Association of improved overall survival with decreased distant metastasis following asparaginase-based chemotherapy and radiotherapy for intermediate- and high-risk early-stage extranodal nasal-type NK/T-cell lymphoma: a CLCG study

摘要

著录项

相似文献

相关主题

期刊订阅